{"id":6014,"date":"2026-02-14T09:24:32","date_gmt":"2026-02-14T09:24:32","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/6014\/"},"modified":"2026-02-14T09:24:32","modified_gmt":"2026-02-14T09:24:32","slug":"roche-abandons-global-diversity-targets-on-concern-over-u-s-executive-orders","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/6014\/","title":{"rendered":"Roche abandons global diversity targets on concern over U.S. executive orders"},"content":{"rendered":"<p>Roche abandons global diversity targets on concern over U.S. executive orders<\/p>\n<p>FRANKFURT, March 19 (Reuters) \u2013 Swiss drugmaker Roche (ROG.S)\u00a0has abandoned global targets for a more diverse workforce to avoid penalties from recent U.S. executive orders, the latest in a slew of companies to do so.<\/p>\n<p>\u00a0<\/p>\n<p>Among measures taken, Roche said its Chief Diversity Offices in the U.S. and at its Basel headquarters \u201cwill focus on inclusion and belonging, and responsibilities will be re-scoped accordingly\u201d. Diversity was not mentioned under the Offices\u2019 new remit.<\/p>\n<p>According to a memo to global staff made available to Reuters, the changes were made to ensure that Roche \u201ccan continue to deliver medicines and diagnostic solutions to patients\u201d.<\/p>\n<p>\u00a0<\/p>\n<p>A number of U.S. <a class=\"text__text__1FZLe text__inherit-color__3208F text__inherit-font__1Y8w3 text__inherit-size__1DZJi link__link__3Ji6W link__underline_default__2prE_\" href=\"https:\/\/www.reuters.com\/world\/us\/factbox-us-companies-drop-diversity-policies-after-trumps-order-2025-02-27\/\" data-testid=\"Link\" rel=\"nofollow noopener\" target=\"_blank\">companies<\/a> have been scaling back diversity, equity and inclusion programmes since U.S. President Donald Trump declared some elements of DEI illegal and threatened possible investigations into firms that practice it.<\/p>\n<p><a href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/roche-abandons-global-diversity-targets-concern-over-us-executive-orders-2025-03-19\/\" target=\"_blank\" rel=\"noopener nofollow\">Read the full article on Reuters.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Roche abandons global diversity targets on concern over U.S. executive orders FRANKFURT, March 19 (Reuters) \u2013 Swiss drugmaker&hellip;\n","protected":false},"author":2,"featured_media":6015,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[124],"tags":[4992,790,134],"class_list":{"0":"post-6014","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-roche","8":"tag-dei","9":"tag-diversity","10":"tag-roche"},"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/6014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=6014"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/6014\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/6015"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=6014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=6014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=6014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}